The NOACs, new oral anticoagulants (although not so new now) have been promoted as equivocal or if not better than warfarin for anticoagulation. Certainly from a consumer point of view it is far easier to manage than clean loading and INR checks.
New oral anticoagulants (NOACs) are recently introduced medications that provide anticoagulation via the oral route by inhibiting specific clotting factors
Dabigatran is a direct thrombin inhibitor; It is viewed as a warfarin replacement; It's use is controversial because the management of bleeding complications is difficult and there is no definitive antidote
an orally active direct Factor Xa inhibitor (a n example of a NOACs or “New Oral Anticoagulants”)